Home >> Tag Archives: Foundation Medicine—

Tag Archives: Foundation Medicine—

Roche buys remainder of Foundation Medicine

June 25, 2018—Roche and Foundation Medicine have entered into a merger agreement for Roche to acquire the outstanding shares of FMI’s common stock not already owned by Roche for $2.4 billion. The companies will focus on using FMI’s comprehensive genomic profile testing to develop treatments for patients with cancer. Foundation Medicine will continue to operate independently. “This is important to ...

Read More »

Foundation Medicine CGP assay available in U.S., 5/18

May 2018—Foundation Medicine announced that FoundationOne CDx, an FDA-approved comprehensive genomic profiling assay for all solid tumors incorporating multiple companion diagnostics, is available in the United States. FoundationOne CDx is a test for patients with advanced cancer and is offered as a nationally covered benefit across all solid tumors for Medicare and Medicare Advantage beneficiaries who meet eligibility requirements.

Read More »

FoundationOne CDx for solid tumors gets FDA OK

Dec. 1, 2017—Foundation Medicine announced Nov. 30 that the FDA approved FoundationOne CDx for solid tumors. The test is intended for use by health care professionals to help inform cancer treatment management in accordance with professional guidelines for patients with solid tumors and is the first FDA-approved test of its kind for all solid tumors. FoundationOne CDx is a next-generation-sequencing–based ...

Read More »

Liquid biopsy assay, 7/16

July 2016—Foundation Medicine has launched an analytically validated and accurate blood-based circulating tumor DNA assay that provides patients and oncologists with a new option for comprehensive genomic profiling when a tissue biopsy is not feasible or when tissue is not available.

Read More »

Foundation offers liquid biopsy assay commercially

May 18, 2016—Foundation Medicine has launched an analytically validated and accurate blood-based circulating tumor DNA assay that provides patients and oncologists with a new option for comprehensive genomic profiling when a tissue biopsy is not feasible or when tissue is not available. The Foundation Assay for Circulating Tumor DNA, or FoundationACT, can identify clinically relevant genomic alterations and delivers this ...

Read More »

Foundation Medicine collaboration, 2/16

February 2016—Foundation Medicine announced a three-way collaboration with Horizon Healthcare Services and Clinical Outcomes Tracking and Analysis to advance precision medicine, improve clinical outcomes, and deliver enhanced value to the health care system in the treatment of patients with metastatic non-small cell lung cancer.

Read More »

Study will test genomics’ impact in metastatic NSCLC

Jan. 27, 2016—Foundation Medicine has formed a three-way collaboration with New Jersey insurer Horizon Healthcare Services and cancer-classification firm Clinical Outcomes Tracking and Analysis to improve treatment of patients with metastatic, non-small cell lung cancer. The organizations initiated a prospective clinical study measuring changes in survival benefit and total cost savings achieved among patients with previously untreated metastatic NSCLC who ...

Read More »

Newsbytes, 10/15

October 2015—A decade later, online laboratory handbook gets makeover: Ten years ago, when Massachusetts General Hospital created an online laboratory handbook, the event crowned many hours of programming and coding by a team of pathologists, who were convinced their labors would dramatically streamline access to information.

Read More »

Foundation offers genomics portal for pathologists

Oct. 1, 2015—Foundation Medicine announced the expansion of its suite of molecular information-based products with GeneKit, a genomics solutions portal for pathologists. GeneKit is designed to facilitate the interpretation of genomic data generated by pathologists from targeted next-generation sequencing and hot-spot assays. A company statement said this integration will help pathologists to more effectively support clinical diagnosis and treatment strategies ...

Read More »
X